Targeting PI3K/AKT pathway in triple-negative breast cancer

被引：39
|
作者：
Delaloge, Suzette [1 ]
DeForceville, Louise [1 ]
机构：
[1] Gustave Roussy, Dept Med Oncol, F-94800 Villejuif, France
来源：
LANCET ONCOLOGY | 2017年 / 18卷 / 10期
关键词：
TUMORS;
D O I：
10.1016/S1470-2045(17)30514-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1293 / 1294
页数：3
相关论文
共 50 条
  • [1] Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review
    Ricardo L. B. Costa
    Hyo Sook Han
    William J. Gradishar
    [J]. Breast Cancer Research and Treatment, 2018, 169 : 397 - 406
  • [2] Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review
    Costa, Ricardo L. B.
    Han, Hyo Sook
    Gradishar, William J.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2018, 169 (03) : 397 - 406
  • [3] Dual targeting of the PI3K-AKT pathway in triple-negative breast cancer
    Colley, Grace
    Eustace, Alexander
    AlSultan, Dalal
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [4] Rujifang inhibits triple-negative breast cancer growth via the PI3K/ AKT pathway
    Jia, Wenyu
    Lin, Xuan
    Chen, Xuezhang
    Li, Hongliang
    Zhang, Xingru
    Zhang, Yuzhuo
    Chen, Yinsong
    Wang, Bin
    Chen, Xikang
    Chen, Ju
    Tian, Huaqin
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2024, 327
  • [5] Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway
    不详
    [J]. BIOSCIENCE REPORTS, 2024, 44 (07)
  • [6] Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway
    Xu, Yonggang
    Fang, Rong
    Shao, Jie
    Cai, Zihao
    [J]. BIOSCIENCE REPORTS, 2021, 41 (04)
  • [7] Piperine enhances doxorubicin sensitivity in triple-negative breast cancer by targeting the PI3K/Akt/mTOR pathway and cancer stem cells
    Hakeem, Andrew N.
    El-Kersh, Dina M.
    Hammam, Olfat
    Elhosseiny, Aliaa
    Zaki, Amr
    Kamel, Kohinour
    Yasser, Lidia
    Barsom, Marina
    Ahmed, Menatallah
    Gamal, Mohamed
    Attia, Yasmeen M.
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
  • [8] Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathway
    Kumar Ganesan
    Cong Xu
    Jianming Wu
    Bing Du
    Qingqing Liu
    Yue Sui
    Cailu Song
    Jinhui Zhang
    Hailin Tang
    Jianping Chen
    [J]. ScienceChina(LifeSciences)., 2024, 67 (09) - 1866
  • [9] Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathway
    Ganesan, Kumar
    Xu, Cong
    Wu, Jianming
    Du, Bing
    Liu, Qingqing
    Sui, Yue
    Song, Cailu
    Zhang, Jinhui
    Tang, Hailin
    Chen, Jianping
    [J]. SCIENCE CHINA-LIFE SCIENCES, 2024, 67 (09) : 1849 - 1866
  • [10] PI3K/AKT/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer
    Zhang, Huan-ping
    Jiang, Rui-yuan
    Zhu, Jia-yu
    Sun, Ke-na
    Huang, Yuan
    Zhou, Huan-huan
    Zheng, Ya-bing
    Wang, Xiao-jia
    [J]. BREAST CANCER, 2024, 31 (04) : 539 - 551
12345